跳至主要内容
临床试验/EUCTR2007-005080-10-GB
EUCTR2007-005080-10-GB进行中(未招募)1 期

Irregular vaginal bleeding with etonorgestrel contraceptive implant - A pilot randomised controlled trial of prophylactic down regulation with a Gonadotrophin releasing hormone analogue prior to implant insertion. - Prophylactic GnRH analogue for contraceptive implant bleeding problems

niversity Hospitals of Leicester NHS Trust0 个研究点目标入组 90 人开始时间: 2007年11月26日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Women aged 20-40 (most likely to have a baseline regular menstrual cycle)
  • 2. Requesting Implanon® for contraception after appropriate counseling and consent
  • 3. Willing to follow study criteria and comply with study procedures
  • 4. Signed informed consent to participate in study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Contraindications to Implanon®:Pregnancy
  • Undiagnosed vaginal bleeding
  • Severe arterial disease
  • Liver adenoma
  • Active Gestational Trophoblastic disease
  • Sex-steroid dependent cancer
  • Enzyme inducing medication
  • 2. Contraindications to GnRHa:Pregnancy
  • Undiagnosed vaginal bleeding
  • Breastfeeding
  • Metabolic bone disease
  • 3. Unwilling to keep a menstrual diary
  • 4. Unwilling to follow study criteria and comply with study procedures
  • 5. Unable to understand patient information leaflet
  • 6. Current involvement in other research projects
  • 7. Within 6 weeks of termination of pregnancy

研究者

发起方
niversity Hospitals of Leicester NHS Trust

相似试验